Search

everythinglearnresearchcommunity

for

Search:↓

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Persistent ED in Propecia users is not due to abnormal blood flow.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Regulatory challenges make developing combination therapies in urology difficult and costly.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

5α-Reductase inhibitors can negatively impact sexual function.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Dutasteride and finasteride don't raise erectile dysfunction risk.

Certain drugs that block specific enzymes can help treat prostate diseases.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.